| Patents for C07K 1 - General processes for the preparation of peptides (51,718) |
|---|
| 01/15/2003 | CN1390854A Process for rourifying insuline |
| 01/15/2003 | CN1390853A Process for preparing thymic peptide |
| 01/15/2003 | CN1390851A Bombesin of Bombina maxima and its preparing process and genes |
| 01/15/2003 | CN1390848A Bradykinin of Bombina maxima and its preparing process and genes |
| 01/15/2003 | CN1390468A Manufacture of transparent protein |
| 01/15/2003 | CN1098932C Method of synthesizing fluorescently labeled protein |
| 01/14/2003 | US6506881 Specific for human milk fat globule; complementarity determining region derived from variable domains of mouse monoclonal antibody |
| 01/14/2003 | US6506879 Endotoxin-free; genetically expressed in bacteria; atherosclerosis and cardiovascular disorder treatment |
| 01/14/2003 | US6506726 Purification of an Echinocandin-type compound by adsorption onto a hydrophobic, reversed phase chromatographic media and eluting with a continuous nearly linear gradient of increasing acetic acid |
| 01/14/2003 | US6506586 Nucleic acids encoding polypeptides having haloperoxidase activity |
| 01/14/2003 | US6506585 Polypeptides having haloperoxidase activity |
| 01/14/2003 | US6506558 Deprotecting nucleoside, nucleotide or amino acid to form polypeptide or polynucleotide |
| 01/14/2003 | CA2250583C Process for the preparation of n-methyl-d-phenylalanyl-n-¬1-¬3-¬(aminoiminomethyl)amino|propyl|-3,3-difluoro-2-oxohexyl|-l-prolinamide |
| 01/10/2003 | CA2390522A1 Enzyme/tag binding and detection system |
| 01/09/2003 | WO2003002591A2 Tlp antigen extract, its preparation and diagnostic applications thereof |
| 01/09/2003 | WO2003002590A2 A protein folding reactor |
| 01/09/2003 | WO2002090923A9 Methods for assembling protein microarrays |
| 01/09/2003 | WO2002032943A3 Modifications of hiv env, gag, and pol enhance immunogenicity for genetic immunization |
| 01/09/2003 | WO2002020558A3 Method for binding, in solution, a peptide and a lipophilic vector and uses thereof |
| 01/09/2003 | US20030009013 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/09/2003 | US20030009012 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/09/2003 | US20030009009 Modified cytokine receptor protein |
| 01/09/2003 | US20030008414 Water-soluble luminescent quantum dots and biomolecular conjugates thereof and related compositions and methods of use |
| 01/09/2003 | US20030008367 Isolation and purification of clostridium botulinum toxins |
| 01/09/2003 | US20030008323 Chemical-library composition and method |
| 01/09/2003 | US20030008302 Sequencing of surface immobilized polymers utilizing microfluorescence detection |
| 01/09/2003 | US20030007967 Nitrosylation of protein SH groups and amino acid residues as a therapeutic modality |
| 01/08/2003 | EP1273918A2 Method of selecting evolved binding members using a native epitope |
| 01/08/2003 | EP1273593A1 Isolation and purification of clostridium botulinum toxins |
| 01/08/2003 | EP1273592A2 Process for the purification of pharmacologically active proteins through cationic exchange chromatography |
| 01/08/2003 | EP1273591A1 Polypeptide and process for measuring living body components using the same |
| 01/08/2003 | EP1272622A1 Method for modification of proteins by transglutaminase |
| 01/08/2003 | EP1272517A2 Multiprotein-complexes comprising a nmda receptor and uses thereof |
| 01/08/2003 | EP1272516A2 Selective linear peptides with melanocortin-4 receptor (mc4-r) agonist activity |
| 01/08/2003 | EP0974111B1 Apparatus and method for automated protein design |
| 01/08/2003 | EP0969918B1 Method for producing structured, self-organized molecular monolayers of individual molecular species |
| 01/08/2003 | EP0859622B1 Extracts of shark cartilage |
| 01/08/2003 | CN1390140A Method for linking molecular substances |
| 01/08/2003 | CN1389567A Ribonuclease extracting process |
| 01/07/2003 | US6504011 Recombinantly produced serum albumin is purified in a series of steps, optionally by incubation with an anion-exchange adsorbent, followed by affinity chromatography employing a hydrophobic solid phase and using a water-soluble lipid anion |
| 01/07/2003 | US6503759 Encoded combinatorial chemistry is provided, where sequential synthetic schemes are recorded using organic molecules, which define choice of reactant, and stage, as the same or different bit of information. Various products can be produced in the |
| 01/07/2003 | US6503508 Detergents |
| 01/07/2003 | CA2076307C Orally-active elastase inhibitors |
| 01/07/2003 | CA2075590C Hydantoin derivatives |
| 01/07/2003 | CA2069154C Polypeptides |
| 01/03/2003 | WO2003001212A2 A method for diagnosing a person having multiple sclerosis |
| 01/03/2003 | WO2003000708A1 Water-soluble polymeric metal ion affinity compositions and methods for using the same |
| 01/03/2003 | WO2003000403A2 Device for simultaneous multiple and high parallel synthesis |
| 01/03/2003 | WO2003000271A2 System and method for the large scale labeling of compounds with radiohalogens |
| 01/03/2003 | WO2003000014A2 Spherical protein particles and methods of making and using them |
| 01/03/2003 | WO2002076927A3 Method for the production of carboxylic acid amides |
| 01/03/2003 | WO2002070111A3 Method for the manufacture of gradient gels and method for analysing biomolecules on ultra-long ipg gels |
| 01/03/2003 | WO2002042449A3 Method for selecting peptide ligands |
| 01/03/2003 | WO2002010387A3 G-protein coupled receptors |
| 01/03/2003 | CA2451351A1 A method for diagnosing a person having multiple sclerosis |
| 01/03/2003 | CA2451185A1 Spherical protein particles and methods of making and using them |
| 01/03/2003 | CA2447594A1 Water-soluble polymeric metal ion affinity compositions and methods for using the same |
| 01/02/2003 | US20030004320 Activated peptides and conjugates |
| 01/02/2003 | US20030004315 Collagen |
| 01/02/2003 | US20030004114 Method of inhibiting fungal growth |
| 01/02/2003 | US20030004094 Control of pH transitions during chromatography |
| 01/02/2003 | US20030003534 Isolation of preferential proteins from cells; obtain cells, incubate with reducing agents and detergent, recover proteins |
| 01/02/2003 | US20030003475 Arrays for detecting nucleic acids |
| 01/02/2003 | US20030003111 Having amino acid sequence which differs from amino acid sequence of a major surface antigen of a wild type hepatitis B virus in that the amino acid at position number 133 of such polypeptide is a threonine rather than a methionine |
| 01/02/2003 | EP1271351A1 Method of anticipating interaction between proteins |
| 01/02/2003 | EP1269195A2 Methods for identifying and isolating tissue-specific lumen-exposed molecules |
| 01/02/2003 | EP1269178A2 A method and device for analysis of charged molecules by solution isoelectric focusing |
| 01/02/2003 | EP1268790A1 Gene coding for erbin, and diagnostic and therapeutic uses thereof |
| 01/02/2003 | EP1268772A2 Peptide and nucleic acid coding therefor for the detection, diagnosis and therapy of diseases of the nervous system |
| 01/02/2003 | EP1268551A2 A METHOD OF PRODUCING IgG |
| 01/02/2003 | EP1268527A2 Nucleic acids, proteins, and antibodies |
| 01/02/2003 | EP1268525A2 Macrocyclic ns3-serine protease inhibitors of hepatitis c virus comprising n-cyclic p2 moieties |
| 01/02/2003 | EP1268523A2 Binding compounds for cc chemokine receptor 5 and methods for identifying them |
| 01/02/2003 | EP1268522A2 Novel lhrh-antagonists, production and use thereof as medicament |
| 01/02/2003 | EP1268521A1 Receptor-binding compounds and methods for identifying them |
| 01/02/2003 | EP1268520A2 Receptor-binding compounds and methods for identifying them |
| 01/02/2003 | EP1268515A1 Process for preparing coagulants for water treatment |
| 01/02/2003 | EP1268514A2 Methods for purifying highly anionic proteins |
| 01/02/2003 | EP1268513A1 Macromolecule detection |
| 01/02/2003 | EP1268512A2 A computer based method for identifying conserved invariant peptide motifs |
| 01/02/2003 | EP1268505A2 Solid phase synthesis method and reagent |
| 01/02/2003 | EP1268052A2 High throughput screening array containing porous material |
| 01/02/2003 | EP1268051A2 Dosing form for reagents, use of said dosing form in organic chemical synthesis and production of said dosing form |
| 01/02/2003 | EP1268050A2 Dosing form for a polymer support, use of said dosing form in organic chemical synthesis and method for production of said dosing form |
| 01/02/2003 | EP1267939A2 Polyglutamic acid-camptothecin conjugates and methods of preparation |
| 01/02/2003 | EP1127259A4 Thromboplastin reagents and methods for preparing and using such reagents |
| 01/02/2003 | EP1030831A4 Process for the preparation of azacycloalkylalkanoyl pseudotetrapeptides |
| 01/02/2003 | EP0981368A4 Mass spectrometry of colonization factors |
| 01/02/2003 | EP0910574B1 Method for discovering novel anthelmintic compounds |
| 01/02/2003 | EP0854725B1 Preparation of pharmaceutical grade hemoglobins by heat treatment in partially oxygenated form |
| 12/31/2002 | USRE37941 Capillary electrophoresis using replaceable gels |
| 12/31/2002 | US6500803 Factor VIIa inhibitors |
| 12/31/2002 | US6500648 Methods for recombinant peptide production |
| 12/31/2002 | CA2069460C Methods and compositions for preparation and use of a herpes protease |
| 12/27/2002 | WO2002103024A2 Stabilized proteins with engineered disulfide bonds |
| 12/27/2002 | WO2002103008A2 Templated molecules and methods for using such molecules |
| 12/27/2002 | WO2002102490A1 Method for the separation of bioproducts |
| 12/27/2002 | WO2002102310A2 Proteins associated with cell growth, differentiation, and death |
| 12/27/2002 | WO2002088189A3 Polysaccharide derivatives that can be photo-activated for immobilising bio-molecules |
| 12/27/2002 | WO2001094587A3 Extracellular messengers |